ClinicalTrials.gg
BiologicalDrug

F8 protein, human clinical trials

studies test it
19
open now
0
in phase 3
9
first study started
2001

Counted the way a researcher would: F8 protein, human with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses F8 protein, human is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
24 Jan 1974 · Koate, Koate-Dvi · BLA 101130 (FDA, Purple Book)
European Union
12 Aug 2013 · Voncento · EMEA/H/C/002493 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Recombinant Factor VIII (Kogenate FS, BAY14-2222)
4
ADVATE
3
Kogenate (BAY14-2222)
2

In one entry with another drug

Given together, or one or the other

Antihemophilic factor, recombinant, manufactured protein-free
5

Studies by the year they started

19 studies that test it; most in 2006 (4)

Studies that test F8 protein, human, by start year
YearStudies
20012
20021
20041
20064
20081
20092
20111
20122
20131
20142
20151
20171

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
4
Phase 3
9
Phase 4
7
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 18 · Other 1

Bayer (9) · Baxalta now part of Shire (8) · CSL Behring (1) · Nanjing Medical University (1)

Often tested with

Tested in the same studies.

Antihemophilic factor, human recombinant (9) · Vonicog alfa (1) · Lonoctocog alfa (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

F8 protein, human is the comparator. A study of two new drugs counts under both.

  • 1NXT007 · Hoffmann-La Roche · next primary completion Sep 2027

Studies

Open first, then newest update. How each study uses F8 protein, human is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

Given beside what is tested · 4 — F8 protein, human is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with F8 protein, human

Codes

What other systems call F8 protein, human · ClinicalTrials.gg INT003681

  • MeSH (NLM) C078147F8 protein, humanOne source NLM
  • UNII (FDA) 839MOZ74GKANTIHEMOPHILIC FACTOR HUMANConfirmed FDA, NLM
  • RxNorm 826070One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.